In a report released yesterday, Ryan Krueger from KBW maintained a Hold rating on AFLAC (AFL – Research Report), with a price target of $83.00. The company’s shares closed yesterday at $84.34.
According to TipRanks, Krueger is a 5-star analyst with an average return of 13.1% and a 71.90% success rate. Krueger covers the Financial sector, focusing on stocks such as Ameriprise Financial, Metlife, and AFLAC.
In addition to KBW, AFLAC also received a Hold from Wells Fargo’s Elyse Greenspan in a report issued yesterday. However, on the same day, Bank of America Securities reiterated a Buy rating on AFLAC (NYSE: AFL).
See the top stocks recommended by analysts >>
AFL market cap is currently $49.43B and has a P/E ratio of 11.15.
Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AFL in relation to earlier this year. Most recently, in December 2023, STEVEN KENT BEAVER, the FSVP, Deputy CFO, Aflac Japan of AFL sold 3,114.00 shares for a total of $257,558.94.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AFLAC (AFL) Company Description:
Georgia-based Aflac, Inc. was founded in 1955. The company provides supplement health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S.
Read More on AFL:
- Aflac Incorporated Announces Fourth Quarter Results, Reports Fourth Quarter Net Earnings of $268 Million, Reiterates Increase in First Quarter Dividend of 19%
- AFL Earnings this Week: How Will it Perform?
- Aflac price target raised to $92 from $85 at BofA
- Aflac downgraded to Underperform from In Line at Evercore ISI
- Trupanion, Aflac to withdraw from development in Japan
